Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Reiniger

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cardiovascular Drugs and Therapy|July 4, 1998
Increasing nitroglycerin release from patches enables circumvention of early nitrate toleranceG Reiniger, G Lehmann
Herz|October 1, 1987
[Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches]G Reiniger, W Rudolph
Herz|October 1, 1985
[Therapy of coronary heart disease with nitroglycerin patches. Behavior of anti-ischemic effectiveness in continuous administration and following patch free interval]G Reiniger, W Rudolph
The American Journal of Cardiology|June 15, 1990
Long-acting, marked antiischemic effect maintained unattenuated during long-term interval treatment with once-daily isosorbide-5-mononitrate in sustained-release formA Beyerle, G Reiniger, W Rudolph
Zeitschrift Fur Kardiologie|January 1, 1986
[Avoidance of tolerance development to long term therapy with nitrates through correct dosage]R Blasini, G Reiniger, W Rudolph
Fortschritte Der Medizin|June 30, 1989
[Long-term therapy with nitrates. How can continuous effectiveness be achieved?]W Rudolph, J Dirschinger, G Reiniger, et al.
Zeitschrift Fur Kardiologie|January 1, 1983
Tolerance development during isosorbide dinitrate treatment: can it be circumvented?W Rudolph, R Blasini, G Reiniger, et al.
Herz|June 1, 1985
[Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine]R Blasini, U Brügmann, G Reiniger, et al.
Herz|June 1, 1984
[Prevention of the development of tolerance to isosorbide dinitrate in interval therapy]R Blasini, G Reiniger, U Brügmann, et al.
Journal of Cardiovascular Pharmacology|February 10, 1998
Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomineG Lehmann, G Reiniger, A Beyerle, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cardiovascular Drugs and Therapy|July 4, 1998
Increasing nitroglycerin release from patches enables circumvention of early nitrate toleranceG Reiniger, G Lehmann
Herz|October 1, 1987
[Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches]G Reiniger, W Rudolph
Herz|October 1, 1985
[Therapy of coronary heart disease with nitroglycerin patches. Behavior of anti-ischemic effectiveness in continuous administration and following patch free interval]G Reiniger, W Rudolph
The American Journal of Cardiology|June 15, 1990
Long-acting, marked antiischemic effect maintained unattenuated during long-term interval treatment with once-daily isosorbide-5-mononitrate in sustained-release formA Beyerle, G Reiniger, W Rudolph
Zeitschrift Fur Kardiologie|January 1, 1986
[Avoidance of tolerance development to long term therapy with nitrates through correct dosage]R Blasini, G Reiniger, W Rudolph
Fortschritte Der Medizin|June 30, 1989
[Long-term therapy with nitrates. How can continuous effectiveness be achieved?]W Rudolph, J Dirschinger, G Reiniger, et al.
Zeitschrift Fur Kardiologie|January 1, 1983
Tolerance development during isosorbide dinitrate treatment: can it be circumvented?W Rudolph, R Blasini, G Reiniger, et al.
Herz|June 1, 1985
[Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine]R Blasini, U Brügmann, G Reiniger, et al.
Herz|June 1, 1984
[Prevention of the development of tolerance to isosorbide dinitrate in interval therapy]R Blasini, G Reiniger, U Brügmann, et al.
Journal of Cardiovascular Pharmacology|February 10, 1998
Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomineG Lehmann, G Reiniger, A Beyerle, et al.
Pageof 3